Standard BioTools Inc. (LAB) vs ORTHOFIX MEDICAL INC. (OFIX)

Standard BioTools Inc. and ORTHOFIX MEDICAL INC. are both Medical Devices companies. ORTHOFIX MEDICAL INC. is the larger, with a market value of $373.1M against $291.7M — 1.3× the size. ORTHOFIX MEDICAL INC. has negative trailing earnings, so its P/E is not meaningful; Standard BioTools Inc. trades at 3.4×. Standard BioTools Inc. grew revenue faster over the last twelve months: 30.2% against 2.99%. Standard BioTools Inc. has the higher net margin (100.4% vs −7.41%) and the lower return on invested capital (−93.9% vs −4.37%). Across the 19 metrics below, Standard BioTools Inc. leads on 12 and ORTHOFIX MEDICAL INC. on 7.

Valuation

Metric LAB OFIX Medical Devices median
P/E 3.36 n/m 22.18
P/S 3.42 0.46 2.70
P/B 0.54 0.90 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA 1.96 26.98 11.78
EV/Sales (2.15) 0.63 2.38
Earnings yield 29.73% (16.31%) (8.22%)
Free cash flow yield (30.83%) (7.80%) (7.80%)

Profitability

Metric LAB OFIX Medical Devices median
Gross margin 50.49% 71.31% 56.01%
Operating margin (112.85%) (4.70%) (15.03%)
Net margin 100.37% (7.41%) (20.40%)
Free cash flow margin (97.61%) (3.34%) (7.24%)
Return on equity 17.61% (13.91%) (15.32%)
Return on assets 14.34% (7.22%) (19.72%)
Return on invested capital (93.89%) (4.37%) (10.33%)

Growth

Metric LAB OFIX Medical Devices median
Revenue growth (TTM) 30.23% 2.99% 8.80%
EPS growth (last fiscal year) 61.54% 29.39% —
Revenue growth, 5-year CAGR (9.19%) 15.13% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LAB OFIX Medical Devices median
Debt to equity 0.00 0.55 0.07
Current ratio 9.10 2.84 2.50
Net debt to EBITDA 1.84 48.90 0.49

Dividend

Metric LAB OFIX Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric LAB OFIX Medical Devices median
Market cap 291.69m 373.11m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack